Clinical Trials on Transthyroxin Amyloidosis Cardiomyopathy
Total 1655 results
-
University Hospital, ToulouseTerminatedCarpal Tunnel Syndrome | Transthyretin AmyloidosisFrance
-
University of CincinnatiThe Christ HospitalWithdrawnParaproteinemias | Amyloidosis | CardiomyopathiesUnited States
-
Universidade do PortoCentro Hospitalar Universitário São João, E.P.E. (CHUSJ); Centro de Investigação... and other collaboratorsRecruitingCarpal Tunnel Syndrome | Transthyretin AmyloidosisPortugal
-
Millennium Pharmaceuticals, Inc.CompletedLight-Chain AmyloidosisUnited States, Canada, France, Germany, Italy
-
Chulalongkorn UniversityUnknown
-
Eidos Therapeutics, a BridgeBio companyWithdrawnTransthyretin-Related (ATTR) Familial Amyloid PolyneuropathyUnited States
-
Criterium, Inc.AmgenCompletedAmyloidosis | Systemic Light Chain AmyloidosisUnited States
-
Kaneka Medical America LLCRecruitingDialysis AmyloidosisUnited States
-
Peking Union Medical College HospitalActive, not recruitingLight Chain (AL) Amyloidosis | Venetoclax | CCND1 TranslocationChina
-
Peking Union Medical College HospitalXian-Janssen Pharmaceutical Ltd.Active, not recruitingAmyloidosis; SystemicChina
-
University of Tennessee Graduate School of MedicineAttralus, Inc.RecruitingSystemic AmyloidosisUnited States
-
Samsung Medical CenterRecruitingCardiac AmyloidosisKorea, Republic of
-
Mayo ClinicEnrolling by invitationCardiac AmyloidosisUnited States
-
University of Tennessee Graduate School of MedicineCompletedSystemic AmyloidosisUnited States
-
University Hospital, ToulouseTerminatedCardiac AmyloidosisFrance
-
Stanford UniversityCompleted
-
Tufts Medical CenterSanofiWithdrawnAmyloidosis | Light Chain (AL) Amyloidosis
-
Mayo ClinicCompletedTTR Cardiac AmyloidosisUnited States
-
Jian LiPeking University First Hospital; Tongji Hospital; Nanfang Hospital of Southern... and other collaboratorsCompletedAmyloidosis; SystemicChina
-
Ionis Pharmaceuticals, Inc.CompletedHealthy Volunteers | hATTR AmyloidosisCanada
-
C.T. Development America, Inc.CompletedAmyloidosisSpain, United States, Italy, Belgium, Netherlands, India, Tunisia, Latvia, Turkey, France, Germany, Estonia, Lithuania, Poland, Russian Federation, Georgia, United Kingdom, Israel, Egypt, Finland, Peru, Sweden, Ukraine
-
M.D. Anderson Cancer CenterTakeda; Janssen PharmaceuticalsActive, not recruitingRecurrent Primary Amyloidosis | Refractory Primary Amyloidosis | Newly Diagnosed Primary AmyloidosisUnited States
-
Life Molecular Imaging GmbHpharmtrace klinische Entwicklung GmbHRecruitingAL Amyloidosis | Cardiac Amyloidosis | ATTR AmyloidosisUnited States, Spain, Germany, United Kingdom
-
Jin Lu, MDRecruiting
-
University of TennesseeFDA Office of Orphan Products DevelopmentCompleted
-
Nexcella Inc.Not yet recruitingLight Chain (AL) AmyloidosisUnited States
-
Virginia Commonwealth UniversityNot yet recruitingAmyloidosis, HereditaryUnited States
-
Nanjing University School of MedicineRecruiting
-
Attralus, Inc.Novotech (Australia) Pty LimitedRecruitingAmyloidosis; SystemicUnited States, Australia, United Kingdom
-
Brigham and Women's HospitalRecruiting
-
University of EdinburghCompleted
-
University of Tennessee Graduate School of MedicineActive, not recruitingSystemic AmyloidosisUnited States
-
The Cleveland ClinicAvid RadiopharmaceuticalsTerminatedCardiac AmyloidosisUnited States
-
University Hospital Center of MartiniquePfizerUnknownCardiac AmyloidosisGuadeloupe, Martinique
-
Shahid Beheshti University of Medical SciencesCompleted
-
Jeffrey ZonderNot yet recruiting
-
Air Force Military Medical University, ChinaNot yet recruitingImmunoglobulin Light-chain Amyloidosis
-
PETHEMA FoundationCompletedPrimary Systemic AmyloidosisSpain
-
National Cancer Institute (NCI)TerminatedPrimary Systemic AmyloidosisUnited States
-
Millennium Pharmaceuticals, Inc.TerminatedRelapsed or Refractory Systemic Light Chain AmyloidosisUnited States, Canada, Spain, Israel, France, Australia, Denmark, Germany, Korea, Republic of, Greece, Netherlands, Brazil, Czechia, Italy, United Kingdom
-
Ionis Pharmaceuticals, Inc.Approved for marketingAmyloidosis, Hereditary
-
Federico II UniversityEnrolling by invitation
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Sweden, Brazil, United States, France, Spain, Germany
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisPortugal, Spain, Sweden, Brazil, United States, France, Germany
-
IRCCS Policlinico S. MatteoCompleted
-
Alnylam PharmaceuticalsCompleted
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited Kingdom
-
Timothy PoteruchaPfizer; American Heart Association; Eidos Therapeutics, a BridgeBio companyRecruiting
-
Assiut UniversityNot yet recruiting